<DOC>
	<DOC>NCT00533312</DOC>
	<brief_summary>A study to determine lipid changing effects of MK0524A when compared to niacin extended release (NIASPAN) and placebo.</brief_summary>
	<brief_title>MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patients must be between the ages of 18 and 70 years Female patients must be premenopausal women that have been surgically sterilized, not pregnant and/or not planning to become pregnant Patient has a history of peptic ulcer or gout Patient is sensitive to niacin or products containing niacin Patient drinks more than 2 alcoholic drinks per day Patient has certain heart disease, cancer, or is HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>